Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4

Blood

Volumn 99, Issue 10, 2002, Pages 3725-3734

  Li, LiQi ^a,b,c   Liu, Daorong ^a,b,c   Hutt Fletcher, Lindsey ^a,b,c   Morgan, Andrew ^a,b,c   Masucci, Maria G ^a,b,c   Levitsky, Victor ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ARTICLE; DENDRITIC CELL; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; STEM CELL; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 0037093229     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3725     Document Type: Article

References (75)

1. Viral strategies of immune evasion
2. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection
3. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes
4. Immunobiology of dendritic cells
5. Human skin Langerhans cells are targets of dengue virus infection
6. Measles virus suppresses cell-mediated immunity by interfering with the survival and function of dendritic and T cells
7. Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis
8. Measles virus infects human dendritic cells and blocks their allo-stimulatory properties for CD4+ T cells
9. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion
10. Inhibition of dendritic cell maturation by herpes simplex virus
11. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus
12. Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen
13. B cells directly tolerize CD8+ T cells
14. B cells turn off virgin but not memory T cells
15. Tolerogenicity of resting and activated B cells
16. Induction of anergy in CD8 T cells by B cell presentation of antigen
17. Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates
18. Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responses
19. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells
20. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
21. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
22. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (gly-ala)-containing protein requires exogenous processing
23. Dendritic cells as the terminal stage of monocyte differentiation
24. Infection of peripheral blood mononuclear cells by Epstein-Barr viruses: Differential induction of interleukin-6 and tumor necrosis factor-alpha
25. Epstein-Barr virus inhibits GM-CSF synthesis by monocytes: Effect on EBV-induced IL-1 and IL-1 receptor antagonist production by neutrophils
26. Infection of primary human monocytes by Epstein-Barr virus
27. Epstein-Barr virus envelope glycoprotein gp350 induced NF-κB activation and IL-1b synthesis in human monocytes-macrophages involving PKC and PI3-K
28. Binding of Epstein-Barr virus major envelope glycoprotein gp350 results in up-regulation of the TNF-α gene expression in monocytic cells via NF-κB involving PKC, PI3-K and tyrosine kinase
29. Effect of interleukin 7 on the in vitro development and maturation of monocyte-derived human dendritic cells
30. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
31. Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect
32. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells
33. Purification and characterization of Epstrein-Barr virus gp/340/220 produced by a bovine papilloma virus expressing system
34. Production and characterization of monoclonal antibodies against the Epstein-Barr virus membrane antigen
35. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells
36. Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame
37. Monoclonal antibody against a 250,000-Dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen
38. Monoclonal antibodies defining distinctive human T cell surface antigens
39. Different programs of activation-induced cell death are triggered in mature activated cytotoxic T-lymphocytes by immunogenic and partially agonistic peptide ligands
40. Biochemical pathways of caspase activation during apoptosis
41. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cystein protease containing two FADD-like domains
42. Proapoptotic Bcl-2 relative of Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity
43. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex
44. Inhibition of human macrophage colony formation by interleukin 4
45. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
46. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells
47. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
48. Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as coreceptors
49. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation
50. Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells
51. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
52. Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors
53. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control
54. Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells
55. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1
56. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferonresponsive pathway
57. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression
58. HLA-DR mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC
59. The IL-4 receptor: Signaling mechanisms and biological functions
60. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus
61. Interaction of T cells with APCs: The serial encounter model
62. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
63. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo
64. Virologic, immunologic, and clinical observation on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis
65. Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation
66. Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface
67. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion
68. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production
69. Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity
70. Epstein-Barr virus: Adaptation to a life within the immune sytem
71. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals
72. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell
73. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus
74. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study
75. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space